<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_38wWZ7k">A text message intervention to support women&apos;s physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol</title>
				<funder ref="#_MBFmZDa">
					<orgName type="full">unknown</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">A</forename><surname>Singleton</surname></persName>
							<email>anna.singleton@sydney.edu.au</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Partridge</surname></persName>
							<idno type="ORCID">0000-0002-7071-0118</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>2</label> Faculty of Medicine and Health , Sydney School Public Health , Prevention Research Collaboration , Charles Perkins Centre , The University of Sydney , Sydney , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Prevention Research Collaboration</orgName>
								<orgName type="department" key="dep3">Charles Perkins Centre</orgName>
								<orgName type="institution" key="instit1">Sydney School Public Health</orgName>
								<orgName type="institution" key="instit2">The University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Raeside</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Regimbal</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Hyun</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>5</label> The George Institute for Global Health , Camperdown , NSW , Australia.</note>
								<orgName type="institution">The George Institute for Global Health</orgName>
								<address>
									<settlement>Camperdown</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>6</label> Department of Cardiology , Westmead Hospital , Sydney , NSW , Australia.</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">K</forename><surname>Sherman</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>3</label> Centre for Emotional Health , Department of Psychology , Macquarie University , Sydney , NSW , Australia.</note>
								<orgName type="department" key="dep1">Centre for Emotional Health</orgName>
								<orgName type="department" key="dep2">Department of Psychology</orgName>
								<orgName type="institution">Macquarie University</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Elder</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>4</label> Westmead Breast Cancer Institute , Westmead Hospital , Sydney , NSW , Australia.</note>
								<orgName type="institution" key="instit1">Westmead Breast Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Westmead Hospital</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>1</label> Faculty of Medicine and Health , Westmead Applied Research Centre (WARC) , The University of Sydney , Westmead , NSW , Australia.</note>
								<orgName type="department" key="dep1">Faculty of Medicine and Health</orgName>
								<orgName type="department" key="dep2">Westmead Applied Research Centre (WARC)</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Westmead</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>5</label> The George Institute for Global Health , Camperdown , NSW , Australia.</note>
								<orgName type="institution">The George Institute for Global Health</orgName>
								<address>
									<settlement>Camperdown</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_zwwaH6d">A text message intervention to support women&apos;s physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">5260A3E7D229116E65432A7433A25255</idno>
					<idno type="DOI">10.1186/s12885-019-5886-8</idno>
					<note type="submission">Received: 29 December 2018 Accepted: 26 June 2019</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T05:07+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_fMnBWmm">Australia New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12618002020268</term>
					<term xml:id="_udSzU9M">17 December 2018 Breast cancer</term>
					<term xml:id="_wm6UbnG">Survivorship</term>
					<term xml:id="_tGEPUTB">Support</term>
					<term xml:id="_M34tByU">Text message</term>
					<term xml:id="_hzJJafy">Self-efficacy</term>
					<term xml:id="_AsQBSNw">Randomised controlled trial</term>
					<term xml:id="_JJ3xybb">mHealth</term>
					<term xml:id="_x6wsS58">Translational research</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_EVA4Uby"><p xml:id="_AyuNG3y"><s xml:id="_yhV6Kfa">Background: Breast cancer is the most common cancer diagnosed in women worldwide.</s><s xml:id="_bTAdbAU">In developed countries, 80-90% of women will survive five years after diagnosis but the transition from hospital-based care to health selfmanagement and self-efficacy can be difficult.</s><s xml:id="_jTVUUxr">Text messaging programs offer a simple and proven way to provide support to people with chronic diseases.</s><s xml:id="_aB7xT57">This study aims to test the effectiveness of a text message support program at improving women's health self-efficacy, and physical and mental health outcomes after breast cancer treatments compared to usual care at 6-months and to understand the barriers and enablers to widespread implementation.</s><s xml:id="_MK2Svpp">Methods: Single-blind randomised control trial (RCT; N = 160) comparing a text message support intervention to usual care in women with breast cancer (recruited from a large tertiary referral hospital in Sydney, Australia).</s><s xml:id="_MCswCVS">The intervention group will receive a six-month text message support program, which consists of semi-personalised, supportive, lifestyle-focused text messages (4 messages/week) in addition to usual care.</s><s xml:id="_KZTWyDv">The control group will receive usual care without the text message program.</s><s xml:id="_sxYuefe">Outcomes will be assessed at 6-months.</s><s xml:id="_GJkCATf">The primary outcome is change in self-efficacy for managing chronic disease.</s><s xml:id="_c9TWMTt">Secondary outcomes include change in clinical outcomes (body mass index), lifestyle outcomes (physical activity levels, dietary behaviours), mood (depression and anxiety scales), quality of life, satisfaction with, and usefulness of the intervention.</s><s xml:id="_h55VYdn">Analyses will be performed on the principle of intention-to-treat to examine differences between intervention and control groups.</s><s xml:id="_txJ2swq">Discussion: This study will test if a scalable and cost-effective text-messaging intervention is effective at improving women's health self-efficacy, as well as physical and mental health outcomes.</s><s xml:id="_sbTh9EC">Moreover, this study will provide essential preliminary data to bolster a large multicentre RCT to helpsupport breast cancer survivors throughout recovery and beyond.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mP4duSN">Background</head><p xml:id="_Z3Fvqwb"><s xml:id="_jMEFajc">Breast cancer is the most common cancer diagnosed in women worldwide <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_UaumNG7">Due to improvements in diagnostics and treatments in developed countries, 80-90% of women survive at least 5 years after their initial diagnosis <ref type="bibr" target="#b1">[2]</ref>.</s><s xml:id="_TaxbS8d">During treatments, patients typically visit their doctors weekly and then gradually reduce to annual visits <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_VMJNTkD">During this transition from hospital-based care to health selfmanagement, breast cancer survivors are encouraged to exercise, maintain a healthy diet and weight <ref type="bibr" target="#b3">[4]</ref>, and, in the majority of cases, adhere to endocrine treatments <ref type="bibr" target="#b4">[5]</ref> to reduce the risk of breast cancer recurrence.</s><s xml:id="_QmHMz7u">Many survivors find this transition physically and mentally difficult due to reduced interaction with, and psychological support from, medical professionals <ref type="bibr" target="#b5">[6]</ref> and/or ongoing treatment side effects <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_Asbvun7">Therefore, simple and cost-effective strategies are needed to support breast cancer survivors during their recovery and beyond.</s></p><p xml:id="_4fS3Pgw"><s xml:id="_TMp7sAz">Self-efficacy is a person's confidence with successfully completing a task.</s><s xml:id="_qZWZ9Zz">Self-efficacy can be improved through 1) learning information 2) motivating goal setting and selfevaluation and 3) achieving goals.</s><s xml:id="_z3cjqJY">Moreover, self-efficacy is domain specific, indicating that people can improve selfefficacy for one task, such as medications adherence, but it will not improve self-efficacy for another task, such as engaging in physical activity <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s xml:id="_Ct2JRFJ">Research shows that educating people about health self-management has been found to improve self-efficacy <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>, reduce inaccurate illness perceptions <ref type="bibr" target="#b8">[9]</ref>, drive behaviour change and improve health outcomes <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_kBXv8Ne">However, education programs commonly involve in-person or phone-based counselling, which are labour and cost intensive <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>.</s></p><p xml:id="_NdsYmnp"><s xml:id="_n2sXh2v">Mobile health (mHealth) is the use of mobile technologies, such as mobile phones and applications, to support healthcare delivery <ref type="bibr" target="#b14">[15]</ref>.</s><s xml:id="_JrGREJ7">mHealth interventions are costsaving compared to traditional education programs <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref> and align well with self-efficacy principles by providing encouragement to achieve health goals, improving health self-management skills through education and goal setting, and tracking progress and accomplishments <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s xml:id="_QD2BS2a">However, most studies target improvements in only one self-efficacy domain.</s><s xml:id="_qVs69SC">For example, a pre-post study using an interactive weight-loss app found that improvements in eating self-efficacy was related to weight-loss in overweight/obese endometrial and breast cancer survivors <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_appJsJf">Another study tested three apps, which used selfguided cognitive behavioural therapy to improve mental health, emotional self-awareness and coping self-efficacy compared to usual care and found that coping-self efficacy mediated improvements in depression scores for people who accessed a national mental health organisation website <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_sn2fM5y">However, it is unclear if mHealth interventions that target multiple self-efficacy domains can promote improvements in various health outcomes simultaneously.</s></p><p xml:id="_3PFxqzs"><s xml:id="_nMQkVCB">Text messages are currently the widest-reaching mHealth intervention, as they do not require the internet for delivery <ref type="bibr" target="#b21">[22,</ref><ref type="bibr" target="#b22">23]</ref>.</s><s xml:id="_dx7K4y8">Globally, there are more than 5 billion unique mobile phone users from urban and rural communities <ref type="bibr" target="#b22">[23]</ref>, and these users send more than 18 billion text messages per day <ref type="bibr" target="#b23">[24]</ref>.</s><s xml:id="_U9t8g6y">Text-messaging has, therefore, been targeted as a simple tool for providing people with health information <ref type="bibr" target="#b21">[22]</ref>.</s><s xml:id="_2ccgFSZ">Recently, the Tobacco, Exercise and Diet Messages (TEXTME) randomised controlled trial (RCT) tested a lifestyle-focused text message intervention (4 messages per week for 6 months), which provided health advice, motivational reminders and support to change lifestyle behaviours compared to usual care for people with coronary heart disease who had recently been hospitalised.</s><s xml:id="_XTUsHbP">At sixmonths, results showed the TEXTME program effective for promoting healthy behaviours and improving clinical outcomes, such as low-density lipoprotein (LDL)-cholesterol, body mass index (BMI), rates of healthy eating and smoking cessation compared to usual care <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref>.</s><s xml:id="_AzpJJEJ">Moreover, participants found the TEXTME program useful (91%) and motivating (77%) during their transition to health self-management <ref type="bibr" target="#b26">[27]</ref>.</s><s xml:id="_2u4fJ8h">For women with breast cancer, text message programs have been shown to help reduce weight, improve exercise frequency, adherence to endocrine therapies <ref type="bibr" target="#b27">[28]</ref> and improve motivation to achieve health goals <ref type="bibr" target="#b28">[29]</ref>.</s><s xml:id="_z23FtPt">Although these studies used strategies that are known to improve selfefficacy, such as providing education and motivational information <ref type="bibr" target="#b6">[7]</ref>, they did not specifically investigate selfreported changes in self-efficacy.</s></p><p xml:id="_uy5Sp6s"><s xml:id="_W95hFVq">The current study aims to improve self-efficacy in multiple domains related to chronic disease risk factors (physical activity, nutrition, social and emotional wellbeing, medication adherence, breast cancer knowledge) by providing educational, motivational and supportive information via text message during the difficult transition from hospital-based care.</s><s xml:id="_NbMSsDn">Therefore, this study aims to test the effectiveness of a six-month text message program <ref type="bibr" target="#b8">[9]</ref> in addition to usual care and test its efficacy in improving women's self-efficacy for managing chronic disease after breast cancer treatments compared to usual care alone.</s><s xml:id="_3fWbwMB">We also aim to determine if the text message program can improve anxiety, depression, BMI, healthy eating behaviours, physical activity and quality of life, and if self-efficacy mediates these improvements.</s><s xml:id="_WCvKw5D">Finally, this study aims to investigate the barriers and enablers to implementing such a program with women recovering from breast cancer treatments.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yA3vkA2">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Z3yTtFS">Study design</head><p xml:id="_pXRkg9X"><s xml:id="_JGCSd8m">Single-blind RCT with a six-month follow-up comparing a text message support intervention to usual care in a population of women with breast cancer (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_YsJbNNW">Written and informed consent will be obtained from all participants, and the study will follow the Consolidated Standards of Reporting Trials guidelines <ref type="bibr" target="#b29">[30]</ref>.</s><s xml:id="_fRr4SRq">Clinical, behavioural and quality of life data will be collected at faceto-face assessments.</s><s xml:id="_VRj8M6u">To maintain blinding, randomisation will occur after the assessment via computer, which delivers an automated text message to participants regarding study groups but does not reveal allocation to the research assistant.</s><s xml:id="_3heVEuM">Primary ethics approval has been received from the Western Sydney Local Health District Human Ethics Research Committee (AU RED HREC/18/WMEAD/281).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mASxD6v">Randomisation and blinding</head><p xml:id="_3WHkPQ6"><s xml:id="_jFEV9Ju">After the baseline assessment, participants will be randomised to either usual care (control) or the text message intervention group in a uniform 1:1 (control:intervention) allocation ratio, using a secured central computer-based randomisation service.</s><s xml:id="_47J3s3J">For each participant, the computer system automatically produces a study identification number, which will be used on all study documents.</s><s xml:id="_myHgmKB">Within 7 days after the enrolment visit, the computer system automatically starts sending the text message program to the participant.</s><s xml:id="_uekTCK3">Therefore, the researcher conducting baseline and six-month face-to-face assessments remains blinded to treatment allocation.</s><s xml:id="_es5GvJp">As an additional precaution and for safety purposes, there will be an independent, unblinded researcher monitoring all incoming text messages.</s></p><p xml:id="_zHpjXFa"><s xml:id="_uT7sjwZ">To validate the self-reported physical activity questionnaire, a subset (32/160) of participants, will be randomly assigned to wear a small (matchbox sized) accelerometer for 7 days <ref type="bibr" target="#b30">[31]</ref> at baseline and follow-up and return it to a member of the research team.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_skyFJja">Study population</head><p xml:id="_6fuGDYh"><s xml:id="_ZyN7EUn">Patients will be eligible to participate if they are female; &gt; 18 years old; diagnosed with breast cancer; have completed breast cancer treatments (surgery, and/or chemotherapy and/or radiation therapy) within the past 18 months (although can still be on endocrine treatment); own an operational mobile phone capable of sending and receiving text messages; and, provide written informed consent.</s><s xml:id="_6MBgQM3">Patients will be excluded if they: are already participating in a text message-based study; have been diagnosed with distant metastatic breast cancer or cannot comply with study requirements (i.e., does not want to return for a follow-up visit, does not want to wear accelerometer).</s><s xml:id="_eQSDPeH">For those people who are ineligible or decline to participate, we will keep a 'screening log' of basic demographic information and reasons for non-participation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FuWDdVd">Study groups</head><p xml:id="_YHwtwsz"><s xml:id="_mUeBdFb">The usual care (control) group will continue to receive usual care from their assigned health professionals, including support from breast care nurses and other allied health professionals.</s><s xml:id="_nNgTjcv">Participants in the usual care group will receive an initial text message welcoming them to the study, but they will not receive the text message support program.</s><s xml:id="_bCMR65n">The control group will also receive a text message reminder approximately six-months after their enrolment, notifying them that they will be contacted to schedule their six-month follow-up visit.</s><s xml:id="_CUVdb8m">Participants in the control group will be offered the opportunity to receive the intervention at the end of the study if they wish.</s></p><p xml:id="_rcegNgt"><s xml:id="_J42JGEB">The intervention group (intervention) will receive a text message support program in addition to usual care, where they will receive four messages per week at random times and days for 6 months.</s><s xml:id="_p6ZHSh6">Participants will be informed that this is a one-way message program and not to reply.</s><s xml:id="_3Kaezf3">However, in case of replies we have a successful system (software program and a centrally located health counsellor with a clinical background) for monitoring all reply messages for safety.</s><s xml:id="_cbk5jRx">The messages will be semi-personalised, where some contain the participant's preferred name and are tailored for individual circumstances and preferences (e.g., taking endocrine treatments or not).</s><s xml:id="_AX9bTvm">The messages will be sent from our team's purpose-built and centralised web-based platform that provides simple registration and automated message delivery <ref type="bibr" target="#b31">[32]</ref>.</s></p><p xml:id="_gbKcDVG"><s xml:id="_cRNEjRx">The message program content and structure was developed according to our previously published model <ref type="bibr" target="#b32">[33]</ref>, which involves a multiphase process of identifying breast cancer clinicians and survivors, hosting interactive workshops, and developing relevant and practical content, grounded in evidence-based guidelines and behaviour change theories and women's lived experiences with breast cancer survivorship.</s><s xml:id="_5HbH7Hn">The text message content (max.</s><s xml:id="_PC3Buak">100-250 characters) will provide support through education, practical health advice for specific and manageable behaviour change, motivational reminders for setting simple goals, and self-monitoring of goal achievement related to self-efficacy for managing chronic disease.</s><s xml:id="_wGqjkHw">Also, the messages strive to reinforce the initial advice and counselling that the patients received in the hospital.</s><s xml:id="_ddR8StM">We used a patient-centred approach to develop messages relevant to women with breast cancer and common challenges of breast cancer survivorship <ref type="bibr" target="#b33">[34]</ref>.</s><s xml:id="_2v85rYC">The following message themes emerged: 1) general breast cancer information; 2) physical activity and nutrition; 3) medication adherence and symptom management; and, 4) emotional and social support and well-being.</s></p><p xml:id="_HYfn7g2"><s xml:id="_pTdAG58">Each week, messages will be selected from the message bank by the software system based on pre-specified algorithms that ensure that participants are receiving the correct messages (intervention vs control) and that the intervention group receives a variety across the four message themes.</s><s xml:id="_yDpP8E9">Both intervention and control groups will receive a welcome message at the beginning of the study and a concluding message at the end of the 6 months.</s><s xml:id="_FaRxVza">All participants will receive training on how to read, reply, save and delete text messages.</s><s xml:id="_ZaMWCcf">All participants will also be provided with the research personnel's contact details and will be contacted at least once during the intervention period to facilitate the six-month follow-up interview.</s><s xml:id="_yUewgY2">A researcher will manage a study mobile phone, and a record will be kept of any incoming messages from participants and all out-going replies from the study health counsellor throughout the study.</s><s xml:id="_UmbXkgM">Any analyses of these incoming text messages will be performed at the group level, except for reporting examples of individual quotes, which will be anonymised to protect the participant's identity.</s><s xml:id="_cDBraHS">Participants from either group can withdraw from the study at any time without giving a reason by replying 'STOP' to any of the messages or contacting a member of the research team, which will activate a process of review and withdrawal from the study.</s><s xml:id="_WJKf3uU">If a participant withdraws, no further information will be collected.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DjtJ9As">Data collection</head><p xml:id="_UVFrKNb"><s xml:id="_ZG9qvD5">Patients will be recruited from the Westmead Breast Cancer Institute, a culturally and ethnically diverse breast cancer institute in Western Sydney, New South Wales, Australia.</s><s xml:id="_mmkGkkN">Potential participants will be identified through physician-referral, self-referral or researchers screening past and present patient appointment lists and invited to participate.</s><s xml:id="_9ccpmKy">If the patient has met all inclusion criteria and none of the exclusion criteria and she has provided written, informed consent to participate, she will be enrolled in the study by a researcher.</s></p><p xml:id="_J6gkUYM"><s xml:id="_Gw3sUf3">The researcher will collect baseline participant information during a face-to-face visit at the Breast Cancer Institute, such as demographics and physical measurements (eg.</s><s xml:id="_8Kb45xH">BMI, body fat percentage) and participants will complete several questionnaires to assess selfreported quality of life, depression, anxiety and physical activity (see Table <ref type="table" target="#tab_0">1</ref>).</s><s xml:id="_6DpbDkF">Participants will be asked information regarding their preferred method of receiving health information and if they currently use any technologies to help them with their health, including breast cancerspecific applications.</s><s xml:id="_DqhcjSr">Past medical history, a list of current prescription medications and chronic disease risk factors will be collected from the participant's medical file.</s></p><p xml:id="_qUEvxsh"><s xml:id="_YjgJExV">Six months after baseline, participants will be contacted to attend a face-to-face follow-up visit at the Breast Cancer Institute.</s><s xml:id="_yajyz5d">Participants will be encouraged not to discuss whether they are receiving the text messages or not with the blinded researcher conducting the assessment.</s><s xml:id="_mvJa923">During this visit, researchers will repeat some of the same measurements as collected during the baseline visit, including the physical measurements and several questionnaires to assess selfreported quality of life, depression, anxiety and physical activity (see Table <ref type="table" target="#tab_0">1</ref>).</s><s xml:id="_DudbRGW">Participants will also be asked about occurrences of any clinical events, healthcare visits and hospitalisations as well as their preferred method of receiving health information and if they currently use any technologies to help them with their health, including breast cancer-specific applications.</s><s xml:id="_DTy6RXc">A list of current prescription medications will be obtained from the participant's medical file or in person, depending on availability.</s><s xml:id="_NvPbHqR">Finally, intervention participants will answer a survey regarding the acceptability, feasibility and utility of the textmessaging program.</s><s xml:id="_dAvVuZ3">All data will be collected either on paper or electronic case report forms and will be monitored for quality assurance according to a prespecified monitoring plan.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cKPFmVA">Data confidentiality and storage</head><p xml:id="_6BDpYE9"><s xml:id="_MqrZeaP">With the participants' consent, the research staff will collect personal information about participants inperson and via participants' medical files, which will only be used for the purpose of this research project and will only be disclosed with the participant's permission, except as required by law.</s><s xml:id="_xfas8XU">All paper data (excluding a confidential contact formname, DOB, mobile number, email) will be quality checked against patient files then entered into a secure password-protected server-based database, which automatically checks data ranges.</s><s xml:id="_An7a3Mt">Information from the contact form will be entered into an enrolment log on a secured, password-protected hospital computer.</s><s xml:id="_z4ByMTA">Only study researchers will have access to study data and results that will be held securely in a locked filing cabinet or on a password-protected computer in Westmead Hospital.</s><s xml:id="_DKTpBCR">Paper and electronic data,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GWTEgHa">✓ ✓</head><p xml:id="_TgPwJqB"><s xml:id="_ERfbM28">Waist circumference in cm <ref type="bibr" target="#b35">[36]</ref> ✓ ✓</s></p><p xml:id="_S8sj22D"><s xml:id="_8Ev99Be">Physical activity level -GPAQ, a validated measure of mild, moderate and vigorous intense activity, as well as sedentary behaviours <ref type="bibr" target="#b37">[38]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5cps3d9">✓ ✓</head><p xml:id="_Udr4cgW"><s xml:id="_uYKZ5GB">Nutrition -Questions adapted from WHO STEPS <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref> ✓ ✓</s></p><p xml:id="_uD67akb"><s xml:id="_kXc6ynq">Quality of lifemeasured by a core 30-item quality of life questionnaire, EORTC QLQ-30 AND ✓ ✓</s></p><p xml:id="_7EKbNZa"><s xml:id="_gqrwA9t">23-item breast cancer-specific sub-scale EORTC QLQ-BR23, which have been widely used and validated in breast can cer populations <ref type="bibr" target="#b40">[41]</ref> ✓ ✓</s></p><p xml:id="_xvEXnWN"><s xml:id="_aSW5wfv">Illness perceptions -BIPQ, a validated 9-item measure used to rapidly assess patients' perceptions of the cognitive and emotional impacts of their illness, including disease severity and causality <ref type="bibr" target="#b41">[42]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CQNQwDq">✓ ✓</head><p xml:id="_WeTRHXs"><s xml:id="_9tffBer">Depression and Anxiety -short-form DASS, which has been validated and tested in numerous patient populations <ref type="bibr" target="#b42">[43]</ref>.</s><s xml:id="_3DKqPyt">This scale will be collected from participants' medical file, unless the scale was completed more than one month prior to the study visit, then participants will complete the scale.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vZBMXUY">✓ ✓</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vCBCRJ9">Randomisation</head><p xml:id="_E7erPdc"><s xml:id="_wkyG8pY">✓ Participant feedback survey ✓ BMI Body Mass Index, WHO STEPS, World Health Organisation STEPwise approach to chronic disease risk factor surveillance; EORTC QLQ-30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core; EORTC QLQ-BR23 Breast Cancer subscale; GPAQ Global Physical Activity Questionnaire; BIPQ Brief Illness Perception Questionnaire; DASS Depression Anxiety Stress Scale</s></p><p xml:id="_E4GWvg2"><s xml:id="_XqVMqGQ">including the consent forms and questionnaires, will be securely destroyed (paper documents shredded, electronic data and backups permanently erased) 5 years after study results are published.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_258JH5Q">Outcomes</head><p xml:id="_7jtAwEY"><s xml:id="_VkFrhhV">The primary outcome is self-efficacy for managing chronic disease (Table <ref type="table" target="#tab_0">1</ref>).</s><s xml:id="_SnVGnJA">Secondary outcomes (Table <ref type="table" target="#tab_0">1</ref>) include clinical measures (BMI, body fat percentage), lifestyle measures (physical activity, nutrition), quality of life, illness perceptions, depression and anxiety and medication adherence (self-report).</s><s xml:id="_yehpRem">We will also be collecting process measures to determine the barriers and enablers to providing a text message support program to breast cancer survivors.</s><s xml:id="_HbCNqzv">Participants will indicate their preferred method of receiving health information and rate the usefulness and appropriateness of the text message intervention.</s><s xml:id="_J3y5ChH">Any incoming text messages from participants throughout the intervention will be coded and analysed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9UYfmpk">Process evaluation</head><p xml:id="_WPGJyVT"><s xml:id="_vsRcuEt">In addition to the stated outcomes, a log will be kept of the times the text messages were sent and what proportion were delivered successfully.</s><s xml:id="_rWNWb97">Moreover, a log will be kept of the number of times the participants attempted to contact the research team and the method of contact (i.e. via phone, email, text message).</s><s xml:id="_BtffQgP">At the end of the blinded follow-up assessment at six-months, intervention participants will complete a study questionnaire with Likert-scaled questions to examine the acceptability and utility of the intervention.</s><s xml:id="_yJQvMDV">This questionnaire will include items that address the acceptability of repeated text messages, identification of which messages the participants remembered, liked or disliked, what they did with the messages (i.e., saved, shared or deleted), the perceived utility of the text messages and opinions regarding the intrusiveness, timing and content suitability of the text messages.</s></p><p xml:id="_JkrvdMa"><s xml:id="_ht3tcn4">A subset of intervention participants will also be invited in person or via telephone to participate in a focus group to provide a more in-depth understanding of the perceived barriers and facilitators to the intervention.</s><s xml:id="_NzEkgzV">These participants will be purposefully selected to diversify the opinions and views shared within the group by choosing participants with ethnically, culturally and socioeconomically diverse backgrounds.</s><s xml:id="_Kgw5mY3">Each focus group will contain approximately 8-10 people and will last approximately 60 min.</s><s xml:id="_NaCkneR">A minimum of two focus groups will be conducted and will be consecutive until no new themes or categories emerge (thematic saturation).</s><s xml:id="_zj2yKjP">It is anticipated that at least 16-20 participants will be invited to take part and will be reimbursed for their travel and parking expenses.</s><s xml:id="_hG43VNk">The focus groups will be conducted by a trained interviewer, and a discussion guide will be used to facilitate and expand the discussion around key feedback themes such as utility and acceptability of the text messages and the perceived health impacts of the intervention.</s><s xml:id="_NQsyMQd">The focus groups will be digitally recorded and transcribed and coded into themes using NVivo version 11.0 (QSR International).</s><s xml:id="_FqGtps8">The coded data will be interpreted, to isolate key themes, contrasts and hierarchies, and to develop coding matrices based on the Framework approach <ref type="bibr" target="#b43">[44]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9yuA6kt">Sample size and statistical analysis plan</head><p xml:id="_aXSHaFe"><s xml:id="_Wb3ZNRk">A mean difference of 1 unit on the average score between patients in the intervention and control groups on the Self-Efficacy for Managing Chronic Disease Scale (6 items) would be a clinically meaningful improvement.</s><s xml:id="_DJQxKTU">A standard deviation of 2.05 for the Self-Efficacy for Managing Chronic Disease Scale (6 items) score (an average of the six items) was published in a similar cancer population <ref type="bibr" target="#b44">[45]</ref>.</s><s xml:id="_mWaamHZ">With a 20% drop out rate, 80% power and type I error of 5%, a total of 160 patients will be needed, with 80 patients in each arm (intervention: control).</s><s xml:id="_qpRQZgF">All analyses will be performed according to the intention-to-treat principle by a blinded statistician.</s><s xml:id="_RzzR7xJ">Continuous variables will be summarised as means and corresponding 95% confidence intervals (CIs), or if the distribution is skewed, as medians and interquartile intervals.</s><s xml:id="_yAemQFz">Categorical variables will be summarised as frequencies and percentages.</s><s xml:id="_GQJj3UK">Primary outcome will be compared between the intervention and the control groups at 6-months using analysis of covariance (ANCOVA), adjusting for the baseline measure of the primary outcome.</s><s xml:id="_5576Ev7">Similarly, for each of the secondary outcomes, ANCOVA, adjusting for the baseline value of the outcome, will be used to compare between the groups at 6-months.</s><s xml:id="_vY3v44x">We will also investigate if changes in secondary outcomes are mediated by self-efficacy scores.</s><s xml:id="_UyU9ykt">A significance level of 0.05 will be used.</s><s xml:id="_7KWBK5c">All analyses will be undertaken using SAS 9.4 for Windows.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XHUs2gE">Discussion</head><p xml:id="_68bvYBs"><s xml:id="_Pn5VRgx">This study aims to facilitate the transition from hospitalbased care to health self-management for women with breast cancer by developing and testing a six-month lifestyle focused text message program in a RCT.</s><s xml:id="_axrt5wb">This simple and cost-effective text message program uses positively-framed, informative and semi-personalised messages to motivate women to maintain healthy behaviours and remain connected with their oncology services.</s><s xml:id="_GccaSuy">Expected results include improvements in primary and secondary outcomes.</s><s xml:id="_qKGX5Rs">If successful, this study will inform a larger multi-centre RCT, with the goal of improving physical and mental health for breast cancer survivors during recovery and beyond.</s><s xml:id="_Dzx35ac">Results of the process measures will elucidate the barriers and enablers to widespread implementation of the text message program, with the ultimate goal of providing survivors with free, long-term out-of-hospital support after treatments.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ug7FGBk">Conclusion</head><p xml:id="_aezW9PW"><s xml:id="_bahaVsW">This study will test the implementation of a six-month text message program to support women's physical and mental health after breast cancer treatments.</s><s xml:id="_T2mknuh">If successful at improving health outcomes, this simple and costeffective program can be easily scaled up to help breast cancer survivors nationally and internationally.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p xml:id="_Kc7WGpa"><s xml:id="_4Ef7yTG">Fig. 1 Study flow diagram.</s><s xml:id="_wvEZhxq">Eligible participants who agree to participate (i.e.</s><s xml:id="_YqP4m9n">sign consent form) are randomised to the intervention (text message program) or control (usual care) by a computerised programme.</s><s xml:id="_AvvcK2w">Baseline, follow-up and focus group assessments are performed</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s xml:id="_hHNQeCH"><ref type="bibr" target="#b36">[37]</ref>y procedures and outcome measures collected at baseline and/or six-month follow-up assessmentsTotal body fat percentage measured with Seca medical Body Composition Analyser (mBCA) 515 with Seca Analytics mBCA 115 software (Seca GmbH &amp; Co. KG, Hamburg, Germany)[37]</s></p></div></figDesc><table><row><cell>Baseline Six-months (+/-</cell></row><row><cell>4 weeks)</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xml:id="_8k3htNv"><p xml:id="_qBXFRZ6"><s xml:id="_J6ydEKz">Acknowledgements A warm thank you to the breast cancer consumers representatives from <rs type="institution">Breast Cancer Network Australia</rs> and <rs type="institution">Westmead Breast Cancer Institute (WBCI)</rs> and all staff and patients at the <rs type="institution">WBCI</rs> for their support with design, recruitment and implementation of the study.</s><s xml:id="_GVmNFEd">A specific thank you to the study's official consumer representative, <rs type="person">Molly Regimbal</rs>, for feedback and support with text message and study design.</s><s xml:id="_Vhshc7b">Thank you to <rs type="person">Simone Marschner</rs> for guidance with the statistical analysis plan and assisting with the sample size calculation.</s><s xml:id="_78RDutG">Finally, we thank staff members of the <rs type="institution">Westmead Applied Research Centre</rs> for their research support, specifically <rs type="person">Caroline Wu</rs>, for assisting with project budgeting and advice on the database development.</s><s xml:id="_eqknAKj">Sponsor The University of Sydney.</s><s xml:id="_Aa4Mawd">Contact details: Clinical Trials Risk and Governance, Research Integrity and Ethics Administration, Level 2, Margaret Telfer Building K07, University of Sydney NSW 2006.</s><s xml:id="_mfygGgx">P: <rs type="grantNumber">028627 5078</rs>.</s><s xml:id="_XMt553h">Email: clinical-trials.research@sydney.edu.au</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_MBFmZDa">
					<idno type="grant-number">028627 5078</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Y2dzB6z">Availability of data and materials</head><p xml:id="_V8MzKGq"><s xml:id="_Z6jcNQq">Not applicable</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2wRjCbE">Ethics approval and consent to participate</head><p xml:id="_qAYQ9gm"><s xml:id="_gReh8N5">Primary ethics approval was received by the Western Sydney Local Health District Human Ethics Research Committee (AU RED HREC/18/WMEAD/281) and study researchers will obtain written, and informed consent from all participants, and the study will follow the Consolidated Standards of Reporting Trials guidelines <ref type="bibr" target="#b29">[30]</ref>.</s><s xml:id="_zDhJrFG">Study data will be disseminated in peerreviewed journals, at scientific meetings, to any organisations interested in translating the program and in the media.</s><s xml:id="_YSJuTTj">In any publications or presentations, group results will be discussed, and will not identify individual participants.</s><s xml:id="_5NHMggb">For qualitative research reporting, direct participant quotes will be used, but pseudonyms will be used to protect participant privacy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_a76XTgU">Consent for publication Not applicable</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3K3MUav">Competing interests</head><p xml:id="_VpN8xZX"><s xml:id="_pkfF5dz">The authors declare that they have no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9x42VbJ">Publisher's Note</head><p xml:id="_Ay3mfBr"><s xml:id="_P5mZg7x">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_ZjfgCAX">Global cancer statistics</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Center</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forman</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.20107</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_w3Mb3eu">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="69" to="90" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_pTh96Ha">Breast cancer in Australia: an overview</title>
		<idno type="DOI">10.15256/joc.2018.8.125.288</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BrdqfCN">Cancer series</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<date type="published" when="2012">2012</date>
			<publisher>AIHW</publisher>
			<pubPlace>Canberra</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Australian Institute of Health and Welfare &amp; Cancer Australia 2012. Breast cancer in Australia: an overview. Cancer series no. 71. Cat. no. CAN 67. Canberra: AIHW.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_dGvuamb">American Society of Clinical Oncology 2006 update of the breast Cancer follow-up and management guidelines in the adjuvant setting</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Khatcheressian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Wolff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Grunfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Muss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Vogel</surname></persName>
		</author>
		<idno type="DOI">10.1200/jco.2006.08.8575</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MqDhFzT">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">31</biblScope>
			<biblScope unit="page" from="5091" to="5097" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, et al. American Society of Clinical Oncology 2006 update of the breast Cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091-7.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_MEsfq5W">Population attributable risk for breast cancer: diet, nutrition, and physical exercise</title>
		<author>
			<persName><forename type="first">M</forename><surname>Maura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>Vecchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Decarli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Talamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Franceschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1093/jnci/90.5.389</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KyQ72y8">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="389" to="394" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maura M, Boyle P, La Vecchia C, Decarli A, Talamini R, Franceschi S. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst. 1998;90(5):389-94.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_PcXJqXS">Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hershman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kushi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fehrenbacher</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-010-1132-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3gZW3js">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="529" to="537" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529-37.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_zcVUC66">Follow-up care after breast cancer treatment: experiences and perceptions of service provision and provider interactions in rural Australian women</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lawler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Spathonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eakin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kXkgzcV">Support Care Cancer</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1975" to="1982" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lawler S, Spathonis K, Masters J, Adams J, Eakin E. Follow-up care after breast cancer treatment: experiences and perceptions of service provision and provider interactions in rural Australian women. Support Care Cancer. 2011;19(12):1975-82.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_SN7Xwv4">Self-efficacy: toward a unifying theory of behavioral change</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bandura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YHMuwUy">Psychol Rev</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">191</biblScope>
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main" xml:id="_GHkQaxv">Social learning theory</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bandura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Walters</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1977">1977</date>
			<publisher>Prenticehall</publisher>
			<pubPlace>Englewood Cliffs</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Bandura A, Walters RH. Social learning theory. Englewood Cliffs: Prentice- hall; 1977.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_sr7Tu8E">Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Ellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weinman</surname></persName>
		</author>
		<idno type="DOI">10.1097/00006842-200207000-00007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qq4ANeX">Psychosom Med</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="580" to="586" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med. 2002;64(4):580-6.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_zF52dR2">The role of selfefficacy in achieving health behavior change</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Strecher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mcevoy</forename><surname>Devellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Rosenstock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AnF2G26">Health Educ Q</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="73" to="92" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Strecher VJ, McEvoy DeVellis B, Becker MH, Rosenstock IM. The role of self- efficacy in achieving health behavior change. Health Educ Q. 1986;13(1):73-92.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_yFErq9Y">Mobile phone messaging for facilitating self-management of long-term illnesses</title>
		<author>
			<persName><forename type="first">T</forename><surname>De Jongh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gurol-Urganci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vodopivec-Jamsek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Car</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Atun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eqw9epS">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">7459</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;(12):Cd007459.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_gzuusQv">Self-efficacy and health behavior among older adults</title>
		<author>
			<persName><forename type="first">D</forename><surname>Grembowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Patrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Diehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Durham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beresford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kay</surname></persName>
		</author>
		<idno type="DOI">10.2307/2137237</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nMxvG7a">J Health Soc Behav</title>
		<imprint>
			<biblScope unit="page" from="89" to="104" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grembowski D, Patrick D, Diehr P, Durham M, Beresford S, Kay E, et al. Self-efficacy and health behavior among older adults. J Health Soc Behav. 1993:89-104.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_U45DPN4">The effects and expense of augmenting usual cancer clinic care with telephone problem-solving counseling</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Downe-Wamboldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Butler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Melanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Coulter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Singleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Keefe</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.ncc.0000300164.90768.ec</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nFRVqKK">Cancer Nurs</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="441" to="453" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Downe-Wamboldt BL, Butler LJ, Melanson PM, Coulter LA, Singleton JF, Keefe JM, et al. The effects and expense of augmenting usual cancer clinic care with telephone problem-solving counseling. Cancer Nurs. 2007;30(6):441-53.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_X8RkUfp">Effectiveness and cost effectiveness of counselling in primary care</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bower</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rowland</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.CD001025.pub2</idno>
		<ptr target="https://doi.org/10.1002/14651858.CD001025.pub2" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rH2YT38">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">1025</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bower PJ, Rowland N. Effectiveness and cost effectiveness of counselling in primary care. Cochrane Database Syst Rev. 2006;(3): CD001025. https://doi. org/10.1002/14651858.CD001025.pub2.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_twPFFhS">mHealth: New horizons for health through mobile technologies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wWnfuCd">World Health Organ</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="66" to="71" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kay M, Santos J, Takane M. mHealth: New horizons for health through mobile technologies. World Health Organ. 2011;64(7):66-71.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_aPMU8Hv">Costeffectiveness of a text message programme for the prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">E</forename><surname>Burn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nghiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jan</forename><forename type="middle">S</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2016-310195</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_25myqYm">Heart</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="893" to="894" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burn E, Nghiem S, Jan S, Redfern J, Rogers A, Thiagalingam A, et al. Cost- effectiveness of a text message programme for the prevention of recurrent cardiovascular events Heart. 2017;103:893-94.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_KNbANWc">What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Iribarren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Falzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Stone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_98VGfxQ">PLoS One</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">170581</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One. 2017;12(2):e0170581.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_NzjEeb6">Apps seeking theories: results of a study on the use of health behavior change theories in cancer survivorship mobile apps</title>
		<author>
			<persName><forename type="first">D</forename><surname>Vollmer Dahlke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Beaudoin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pulczinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Ory</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gFDzehP">JMIR MHealth UHealth</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e31</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vollmer Dahlke D, Fair K, Hong YA, Beaudoin CE, Pulczinski J, Ory MG. Apps seeking theories: results of a study on the use of health behavior change theories in cancer survivorship mobile apps. JMIR MHealth UHealth. 2015;3(1):e31.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_eya7xAa">Effective techniques in healthy eating and physical activity interventions: a metaregression</title>
		<author>
			<persName><forename type="first">S</forename><surname>Michie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Whittington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcateer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gupta</surname></persName>
		</author>
		<idno type="DOI">10.1037/a0016136</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9mmyNUu">Health Psychol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">690</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta- regression. Health Psychol. 2009;28(6):690.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_BAFQ9rZ">Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mccarroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Armbruster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pohle-Krauza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Lyzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Nash</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2014.12.025</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wCkHSrH">Gynecol Oncol</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="508" to="515" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McCarroll ML, Armbruster S, Pohle-Krauza RJ, Lyzen AM, Min S, Nash DW, et al. Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application. Gynecol Oncol. 2015;137(3):508-15.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_pYZXbAe">A randomized controlled trial of three smartphone apps for enhancing public mental health</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kazantzis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rickwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rickard</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brat.2018.08.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_u9bvyJa">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="75" to="83" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bakker D, Kazantzis N, Rickwood D, Rickard N. A randomized controlled trial of three smartphone apps for enhancing public mental health. Behav Res Ther. 2018;109:75-83.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_942Ve8w">Text messaging as a tool for behavior change in disease prevention and management</title>
		<author>
			<persName><forename type="first">H</forename><surname>Cole-Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kershaw</surname></persName>
		</author>
		<idno type="DOI">10.1093/epirev/mxq004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UpXgfpQ">Epidemiol Rev</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="56" to="69" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32(1):56-69.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title level="m" type="main" xml:id="_wFjA2Sd">The mobile economy</title>
		<ptr target="https://www.gsmaintelligence.com/research/?file=b9a6e6202ee1d5f787cfebb95d3639c5&amp;download" />
		<imprint>
			<date type="published" when="2019">2019</date>
			<publisher>GSMA Intelligence</publisher>
			<biblScope unit="page" from="1" to="56" />
		</imprint>
	</monogr>
	<note type="raw_reference">GSMA Intelligence. The mobile economy; 2019. p. 1-56. Available from: https://www.gsmaintelligence.com/research/?file= b9a6e6202ee1d5f787cfebb95d3639c5&amp;download.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main" xml:id="_peUJ3wu">How many texts do people send every day?</title>
		<author>
			<persName><forename type="first">K</forename><surname>Burk</surname></persName>
		</author>
		<ptr target="http://www.trtest.xyz/blog/how-many-texts-people-send-per-day/" />
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burk K. How many texts do people send every day? 2016. Available at: http://www.trtest.xyz/blog/how-many-texts-people-send-per-day/.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_J9U3txy">Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hackett</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2015.10945</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PrYCgcr">Jama</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1255" to="1263" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. Jama. 2015;314(12):1255-63.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_czBF7dY">Patterns, predictors and effects of texting intervention on physical activity in CHD-insights from the TEXT ME randomized clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487316664190</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_U8EBCdb">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1894" to="1902" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thakkar J, Redfern J, Thiagalingam A, Chow CK. Patterns, predictors and effects of texting intervention on physical activity in CHD-insights from the TEXT ME randomized clinical trial. Eur J Prev Cardiol. 2016;23(17): 1894-902.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_ZfMcYjV">Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Coorey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0163929</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CqnxSPg">PLoS One</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">163929</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Santo K, Coorey G, Thakkar J, Hackett M, Thiagalingam A, et al. Factors influencing engagement, perceived usefulness and behavioral mechanisms associated with a text message support program. PLoS One. 2016;11(10):e0163929.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_yuHC3KE">Bidirectional text messaging to monitor endocrine therapy adherence and patient-reported outcomes in breast Cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Mougalian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Jhaveri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abu-Khalaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Hofstatter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ee9mtRK">JCO Clin Cancer Inf</title>
		<imprint>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mougalian SS, Epstein LN, Jhaveri AP, Han G, Abu-Khalaf M, Hofstatter EW, et al. Bidirectional text messaging to monitor endocrine therapy adherence and patient-reported outcomes in breast Cancer. JCO Clin Cancer Inf. 2017;(1):1-10.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_XscFj5X">Women&apos;s perceptions of participation in an extended contact text message-based weight loss intervention: an explorative study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Job</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Spark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Fjeldsoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Eakin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Reeves</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4rvykth">JMIR MHealth UHealth</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Job JR, Spark LC, Fjeldsoe BS, Eakin EG, Reeves MM. Women&apos;s perceptions of participation in an extended contact text message-based weight loss intervention: an explorative study. JMIR MHealth UHealth. 2017;5(2).</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_bxc6UE3">CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<idno type="DOI">10.1186/1741-7015-8-18</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xJXCf8V">BMC Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">18</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_hUJG985">The CHOICE (Choice of health options in prevention of cardiovascular events) replication trial: study protocol</title>
		<author>
			<persName><forename type="first">L</forename><surname>Neubeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Briffa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bauman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Freedman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_r6WKhFT">BMC Cardiovasc Disord</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">25</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Neubeck L, Redfern J, Briffa T, Bauman A, Hare D, Freedman S. The CHOICE (Choice of health options in prevention of cardiovascular events) replication trial: study protocol. BMC Cardiovasc Disord. 2008;8:25.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_nKkY8Jj">Design Considerations in Development of a Mobile Health Intervention Program: The TEXT ME and TEXTMEDS Experience</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Mcewan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.5996</idno>
		<ptr target="https://doi.org/10.2196/mhealth.5996" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_GsHKb2K">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">127</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thakkar J, Barry T, Thiagalingam A, Redfern J, McEwan AL, Rodgers A, Chow CK. Design Considerations in Development of a Mobile Health Intervention Program: The TEXT ME and TEXTMEDS Experience. JMIR Mhealth Uhealth. 2016;4(4):e127. https://doi.org/10.2196/mhealth.5996.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_DAW7DNZ">Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events</title>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jan</forename><forename type="middle">S</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<idno type="DOI">10.1177/2047487312449416</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CavtfXM">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="492" to="499" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfern J, Thiagalingam A, Jan S, Whittaker R, Hackett ML, Mooney J, et al. Development of a set of mobile phone text messages designed for prevention of recurrent cardiovascular events. Eur J Prev Cardiol. 2014;21(4):492-9.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_ew4vb5W">Breast cancer survivors: information and support after treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cappiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tish</forename><surname>Knobf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Erdos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1177/1054773807306553</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DHxS7dj">Clin Nurs Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="278" to="293" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cappiello M, Cunningham RS, Tish Knobf M, Erdos D. Breast cancer survivors: information and support after treatment. Clin Nurs Res. 2007; 16(4):278-93.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_Ck3N4ek">The English and Spanish self-efficacy to manage chronic disease scale measures were validated using multiple studies</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Ritter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lorig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ff2nWVh">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1265" to="1273" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ritter PL, Lorig K. The English and Spanish self-efficacy to manage chronic disease scale measures were validated using multiple studies. J Clin Epidemiol. 2014;67(11):1265-73.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_8jtnNsK">Anthropometric standardization reference manual</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Lohman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Martorell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XXFgd5V">Champaign: Human kinetics books</title>
		<imprint>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign: Human kinetics books; 1988.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_KDxxayJ">Generation of normal ranges for measures of body composition in adults based on bioelectrical impedance analysis using the seca mBCA</title>
		<author>
			<persName><forename type="first">S</forename><surname>Peine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Knabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Carrero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brundert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wilhelm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ewert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cwqRVjV">Int J Body Comp Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="67" to="76" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Peine S, Knabe S, Carrero I, Brundert M, Wilhelm J, Ewert A, et al. Generation of normal ranges for measures of body composition in adults based on bioelectrical impedance analysis using the seca mBCA. Int J Body Comp Res. 2013;11:67-76.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_ZWgBnkP">Global physical activity questionnaire (GPAQ): nine country reliability and validity study</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Bull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Maslin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Armstrong</surname></persName>
		</author>
		<idno type="DOI">10.1123/jpah.6.6.790</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_edkcBy9">J Phys Act Health</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="790" to="804" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009; 6(6):790-804.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_r5U7xgx">Physical activity in 22 African countries: results from the World Health Organization STEPwise approach to chronic disease risk factor surveillance</title>
		<author>
			<persName><forename type="first">R</forename><surname>Guthold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Louazani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cowan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bovet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Damasceno</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2011.03.008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A4s2msg">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="52" to="60" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guthold R, Louazani SA, Riley LM, Cowan MJ, Bovet P, Damasceno A, et al. Physical activity in 22 African countries: results from the World Health Organization STEPwise approach to chronic disease risk factor surveillance. Am J Prev Med. 2011;41(1):52-60.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<idno type="DOI">10.1007/978-1-4615-0071-1_3</idno>
		<title level="m" xml:id="_g7zamG2">v2.1 WSICaE. The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS)</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organisation</publisher>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">v2.1 WSICaE. The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS). Geneva: World Health Organisation; 2008.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_86Hpg4J">The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sprangers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Groenvold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Arraras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Velde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Muller</surname></persName>
		</author>
		<idno type="DOI">10.1200/jco.1996.14.10.2756</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_92WDqH9">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2756" to="2768" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sprangers M, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756-68.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_Bz3mndK">The brief illness perception questionnaire</title>
		<author>
			<persName><forename type="first">S</forename><surname>Basu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Poole</surname></persName>
		</author>
		<idno type="DOI">10.1093/occmed/kqv203</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3kCTy3C">Occup Med</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="419" to="420" />
			<date type="published" when="2016">2016</date>
			<pubPlace>Oxford, England</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Basu S, Poole J. The brief illness perception questionnaire. Occup Med (Oxford, England). 2016;66(5):419-20.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_jzvVQN7">A study on the reliability and validity of the short form of the depression anxiety stress scale (DASS-21)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Siamak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bahram</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A5CbDX7">Journal of social sciences and humanities of Shiraz University</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="65" to="77" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Special issue in education</note>
	<note type="raw_reference">Siamak S, Bahram J, A study on the reliability and validity of the short form of the depression anxiety stress scale (DASS-21), Journal of social sciences and humanities of Shiraz University, 2007, Vol 26, Number 3 (52) (Special issue in education); Page(s) 65-77.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_av56SFN">Qualitative data analysis: the framework approach</title>
		<author>
			<persName><forename type="first">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Firth</surname></persName>
		</author>
		<idno type="DOI">10.7748/nr2011.01.18.2.52.c8284</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_raZchtt">Nurs Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="52" to="62" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smith J, Firth J. Qualitative data analysis: the framework approach. Nurs Res. 2011;18(2):52-62.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_kNU92Ke">Cancer survivors&apos; self-efficacy to self-manage in the year following primary treatment</title>
		<author>
			<persName><forename type="first">C</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Breckons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cotterell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Barbosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Calman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Corner</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11764-014-0384-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3bhep4d">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="19" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foster C, Breckons M, Cotterell P, Barbosa D, Calman L, Corner J, et al. Cancer survivors&apos; self-efficacy to self-manage in the year following primary treatment. J Cancer Surviv. 2015;9(1):11-9.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
